Nature’s Sunshine price target raised to $22 from $21 at Canaccord

Canaccord raised the firm’s price target on Nature’s Sunshine (NATR) to $22 from $21 and keeps a Buy rating on the shares. The firm updated its model following strong Q2 results. The strong performance with momentum exiting the quarter led management to raise both sales and adj. EBITDA guidance for the year despite continued macro uncertainty in some markets such as Taiwan and Korea. Canaccord believes this highlights management’s confidence in current trends and ability to execute on their growth strategy.